Global 3D Bioprinting Industry

Global 3D Bioprinting Industry

  • April 2021 •
  • 136 pages •
  • Report ID: 6030513 •
  • Format: PDF
Abstract:
- Global 3D Bioprinting Market to Reach $2.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for 3D Bioprinting estimated at US$768.9 Million in the year 2020, is projected to reach a revised size of US$2.8 Billion by 2027, growing at a CAGR of 20.4% over the analysis period 2020-2027. Living Cells, one of the segments analyzed in the report, is projected to record a 22.6% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hydrogels segment is readjusted to a revised 20.7% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $228.3 Million, While China is Forecast to Grow at 19.5% CAGR
- The 3D Bioprinting market in the U.S. is estimated at US$228.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$479 Million by the year 2027 trailing a CAGR of 19.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.5% and 17.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.
- Extracellular Matrices Segment to Record 16.6% CAGR
- In the global Extracellular Matrices segment, USA, Canada, Japan, China and Europe will drive the 16.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$125.4 Million in the year 2020 will reach a projected size of US$364.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$340.2 Million by the year 2027.

- Select Competitors (Total 34 Featured) -
  • 3D Bioprinting Solutions
  • 3D Systems
  • Advanced Solutions Life Sciences
  • Allevi Inc.
  • Aspect Biosystems Ltd.
  • Bio3D Technologies
  • Cellink
  • Cellink Global
  • Cyfuse Biomedical K.K.
  • Digilab, Inc.
  • Envisiontec
  • Gesim
  • Inventia Life Science Pty Ltd.
  • Materialise NV
  • Nano3D Biosciences, Inc.
  • Oceanz 3D printing & Additive Manufacturing
  • Organovo Holdings, Inc.
  • Poietis
  • Regemat 3D S.L.
  • Regenhu
  • Regenovo Biotechnology Co., Ltd.
  • Rokit Healthcare
  • Solidscape
  • Stratasys Ltd.
  • Tevido Biodevices
  • Vivax Bio, LLC
  • Voxeljet